To test the role of p38 MAPKs in the ESCC malignant phenotype regulated by RPS15, we selected SB203580, a small-molecule inhibitor of p38 MAPK, to inhibit the activation of the p38 MAPK pathway. The gene discussed is RPS15; the disease is esophageal squamous cell carcinoma.